{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:14:35Z","timestamp":1760188475480},"reference-count":11,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.leukres.2004.11.021","type":"journal-article","created":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T18:34:53Z","timestamp":1110566093000},"page":"735-738","source":"Crossref","is-referenced-by-count":4,"title":["GM-CSF does not increase CD20 antigen expression on chronic lymphocytic leukemia lymphocytes"],"prefix":"10.1016","volume":"29","author":[{"given":"M\u00fcnci","family":"Ya\u011fc\u0131","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130rem","family":"Akar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fclsan T\u00fcrk\u00f6z","family":"Sucak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rauf","family":"Haznedar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.leukres.2004.11.021_bib1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.seminhematol.2004.05.005","article-title":"Advances in the use of monoclonal antibodies in the therapy of chronic lymphocytic leukemia","volume":"41","author":"Lundin","year":"2004","journal-title":"Semin Hematol"},{"issue":"5","key":"10.1016\/j.leukres.2004.11.021_bib2","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1182\/blood.V98.5.1326","article-title":"Rituximab therapy of patients with B-cell chronic lymphocytic leukemia","volume":"98","author":"Huhn","year":"2001","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.leukres.2004.11.021_bib3","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1182\/blood-2002-06-1639","article-title":"Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significance","volume":"101","author":"Manshouri","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2004.11.021_bib4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0145-2126(99)00206-4","article-title":"Effects of cytokines on CD20 antigen expression on tumor cells from patients with chronic lymphocytic leukemia","volume":"24","author":"Venugopal","year":"2000","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2004.11.021_bib5","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","article-title":"National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia, revised guidelines for diagnosis and treatment","volume":"87","author":"Cheson Bd","year":"1996","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2004.11.021_bib6","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1182\/blood-2002-06-1714","article-title":"Amount of spontaneous apoptosis detected by Bax\/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML)","volume":"101","author":"Del Poeta","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2004.11.021_bib7","first-page":"33","article-title":"Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases","volume":"87","author":"Chow","year":"2002","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.leukres.2004.11.021_bib8","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/cncr.11238","volume":"97","author":"Tsimberidou","year":"2003","journal-title":"Cancer"},{"issue":"January (1)","key":"10.1016\/j.leukres.2004.11.021_bib9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1182\/blood-2002-04-1258","article-title":"Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)","volume":"101","author":"Byrd","year":"2003","journal-title":"Blood"},{"issue":"Suppl. 6","key":"10.1016\/j.leukres.2004.11.021_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/sonc.2002.32747","article-title":"Beyond immunochemotherapy: combinations of rituximab with cytokines interferon-alpha2a and granulocyte colony stimulating factor","volume":"2","author":"Kimby","year":"2002","journal-title":"Semin Oncol"},{"issue":"6","key":"10.1016\/j.leukres.2004.11.021_bib11","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1182\/blood-2004-01-0039","article-title":"Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas","volume":"104","author":"Teeling","year":"2004","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212605000378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212605000378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T09:01:04Z","timestamp":1586163664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212605000378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":11,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0145212605000378"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2004.11.021","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}